Ungakuthuthukisa Kanjani I-Premium Longevity, Amandla Nezengezo Zempilo Yokuqonda nge-Liposomal NAD+ Powder

Kubanikazi bemikhiqizo yezithako ezingeziwe, ososayensi bokwakha, kanye nabaphathi bokuthengwa kwempahla abathuthukisa{0}}isizukulwane esilandelayo imikhiqizo enempilo yokuguga,liposomal NAD+inikeza isisekelo esisekelwe ngokwesayensi sokwakhiwa kwe-premium kuzo zonke izigaba zezempilo zabathengi eziningi. I-NAD+ (i-nicotinamide adenine dinucleotide) iyi-coenzyme ebalulekile ekhona kuwo wonke amangqamuzana aphilayo, ibalulekile ekukhiqizeni amandla eselula, ukulungisa i-DNA, nomsebenzi we-sirtuin{2}}izindlela ezimaphakathi nokuguga okunempilo. Kodwa-ke, izithasiselo ezijwayelekile zomlomo ze-NAD+ ngokomlando ziye zabhekana nomkhawulo obalulekile: I-NAD+ ikhombisa ukufinyeleleka kwe-membrane okulinganiselwe ngenxa yobukhulu bayo be-molecular kanye ne-polarity, okungase kukhawulele ukusebenza kahle kokulethwa komlomo kanye namandla okubunjwa.I-Liposomal NAD+ powderibhekana nalokhu ngokusebenzisa i-phospholipid encapsulation, eyenza izinkampani zithuthukise imikhiqizo ehlukene ezimakethe ezikhula ngokushesha zesikhathi eside, amandla, kanye nezimakethe zezengezo zezempilo.

 

 

 

Ngokwemibiko yezimboni, isithasiselo se-NAD+ somhlaba wonke kanye nezimakethe ezikhuthazayo ze-NAD+ zithola ukukhula okuqinile, okuqhutshwa ukwanda kwentshisekelo yabathengi yokuphila isikhathi eside, impilo yamaselula, kanye nemikhiqizo yokuguga enempilo. Imakethe ye-NAD+ ekhuthazayo kulindeleke ukuthi ikhule ku-CAGR yamadijithi amabili- ngo-2030.

Amathrendi asafufusa abumba isigaba: amasistimu okulethwa athuthukile afana ne-liposomal encapsulation ayahlolwa ukuze kuthuthukiswe ukuqina kwesithako nokusebenza kahle kokulethwa. Amafomu e-Liposomal athola ukuduma ngamandla awo okuthuthukisa ukutholakala kwe-bioavailability, okuvumela imikhiqizo ukuthi ihlukanise emakethe egcwele abantu. Izinhlelo zokusebenza zinwebeka ngaphezu kokuguga okunempilo ukuya ekusebenzeni kwengqondo, i-energy metabolism, nokudla kwezemidlalo. Okwemikhiqizo ye-B2B,liposomal NAD+inikeza indlela eya ekumisweni kwe-premium kule makethe ekhulayo.

 

 

Isayensi Yokuguga Okunempilo

Amazinga e-NAD+ ehla ngesikhathi sokuguga ngokulandelana kwesikhathi, futhi lokhu kwehliswa kuhlotshaniswa nezimpawu eziningi zokuguga, okuhlanganisa ukungasebenzi kahle kwe-mitochondrial, ukungazinzi kwe-genomic, kanye nokuxhumana kwamaselula okushintshile. I-NAD+ isebenza njenge-cofactor ebalulekile yama-sirtuin-umndeni we-NAD{4}}ama-enzyme ancikile alawula ukuvela kwezakhi zofuzo, ukulungiswa kwe-DNA, kanye ne-metabolism. Njengoba ukutholakala kwe-NAD+ kuncipha ngokuya ngeminyaka, umsebenzi we-sirtuin uyancipha, okubangela izinguquko{7}}ezihlobene nobudala.

Indlela ye-NAD+/sirtuin ifundwe kabanzi ngendima yayo engaba khona ekulawuleni i-metabolic, impendulo yengcindezi, nezindlela zokuguga ezinempilo. I-NAD+ metabolism kanye nomsebenzi we-sirtuin kuxhumene kakhulu nezimpendulo zengcindezi yeselula kanye nokulawulwa kwe-metabolic.

Ukucatshangelwa Kokwakhiwa Kwemikhiqizo Yesikhathi Eside

Lapho uthuthukisa{0}}izithako ezigxilwe zempilo ende ngeliposomal NAD+, abaklami kufanele bacabangele:

Isici Sokwakha	Ukucabangela
Ukulungiselela umthamo	Ucwaningo lwabantu lokuqala luhlole imithamo ezungeze i-1,000 mg/day liposomal NAD+
Ukubalwa kwabantu okuqondisiwe	Abantu asebekhulile abaphathelene nokuguga okunempilo
Izithako ze-Synergistic	I-Resveratrol, i-CoQ10, i-PQQ, i-glutathione
Ifomethi yokulethwa	Amaphilisi, amaphilisi, amaphakethe wenduku

I-Liposomal NAD+ inika amandla amabhrendi ukwenza imikhiqizo ekhuluma ngebhayoloji eyisisekelo yokuguga okunempilo, ehlukanisa{1}}ngobuchwepheshe bokulethwa okusekelwe kwesayensi.

 

 

I-NAD+ kanye Nokukhiqiza Amandla Eselula

I-NAD+ idlala indima ebalulekile ekukhiqizweni kwe-ATP. Ngesikhathi sokusabela kwe-catabolic-okuhlanganisa i-glycolysis ku-cytoplasm kanye nomjikelezo we-tricarboxylic acid (TCA) ku-mitochondria{3}}I-NAD+ yamukela ama-electron, enze i-NADH. I-NADH ekhiqizwayo ibe isivalelwa ku-mitochondrion, iletha-ama-electron anamandla aphezulu ochungechungeni lwezokuthutha lwama-electron, lapho i-ATP ikhiqizwa khona nge-oxidative phosphorylation.

I-NAD(H) ingasebenza njengenzwa yamandla exhumanisa ukutholakala komsoco, isimo samandla eselula, nokukhiqizwa kwe-ATP. Uma amazinga e-NAD+ anele, amaseli akhiqiza i-ATP ngempumelelo nge-oxidative phosphorylation. Ngesikhathi sokuncipha kwe-NAD+, amaseli avame ukushintshela ku-anaerobic glycolysis, ehlisa ukusebenza kahle kokukhiqiza kwe-ATP.

Amasu Okwakha Emikhiqizo Yamandla

Ngokwakhiwa kwamandla namandla,liposomal NAD+inikeza izinzuzo ezihlukile:

Isici Sokwakha	Ukucabangela
Ukubalwa kwabantu okuqondisiwe	Abantu abadala abakhuthele, ochwepheshe, abantu abafuna amandla aqhubekayo
Izithako ezihambisanayo	I-CoQ10, B-amavithamini, ama-adaptogens
Amafomethi omkhiqizo	Amaphilisi, isibhamu esiwuketshezi, iziphuzo ezisebenzayo
Ukuma	Amandla eselula, ukwesekwa kwe-mitochondrial

Izici zokulethwa kweliposomal NAD+ikwenze kube inketho ekhangayo yesithako yamandla-ekuhlanganiseni okugxilile okuqondiswe kumetabolism yeselula kanye nezindlela zempilo ze-mitochondrial.

 

 

Ubufakazi Obuvelayo Bokusekelwa Komsebenzi Wokuqonda

Isigaba sezempilo yengqondo simele ithuba lokukhula elibalulekileliposomal NAD+ukwakheka. Ucwaningo luphakamisa ukuthi i-NAD+ metabolism idlala indima ku-homeostasis yamandla obuchopho nokusebenza kwe-neuronal.

I-NAD+ ne-NADH idlala indima ebalulekile ekuhlanganiseni kwe-ATP nasekulawuleni amandla e-metabolic ebuchosheni futhi ibalulekile ezinqubweni ze-metabolic ezifana ne-glycolysis, i-ketolysis, -i-oxidation, nomjikelezo we-TCA. I-placebo engahleliwe{3}}isilingo esilawulwayo se-nicotinamide riboside (NR){4}}isanduleli se-NAD+{6}}kubantu abadala asebekhulile abanokukhubazeka okuncane kokucabanga sithole ukuthi i-NR ikhulise kakhulu ukugxiliswa kwe-NAD+ egazini. Ukwengezwa kwe-Acute NR nakho kukhonjisiwe ukwandisa amazinga e-cerebral NAD+ kumavolontiya abantu abanempilo.

Nakuba ubufakazi bomtholampilo obuningi kuze kube manje buhilela izandulela ze-NAD+ esikhundleni sokuqondisa i-NAD+, lokhu okutholakele kusikisela ukuthi kungenzeka kusetshenziswe ukwakheka okuhlobene kwe-NAD{2}}kumpilo yengqondo.Lo mehluko ubalulekile ukuze abaklami bawuqonde lapho benza imikhiqizo futhi bexhumana namakhasimende e-B2B.

Ukucatshangelwa Kokwakhiwa Kwempilo Yengqondo

Lapho uthuthukisa izithasiselo zempilo yomqondo ngeliposomal NAD+:

Isici Sokwakha	Ukucabangela
Izibalo eziqondiwe	Abantu asebekhulile, abantu abathintekayo ngamandla okuqonda
Izithako ezingaba yi-synergistic	I-Omega-3 DHA/EPA, i-phosphatidylserine, amavithamini e-B
Amafomethi okulethwa	Amaphilisi, ama-softgels, iziphuzo ezisebenzayo
Izindlela ezibalulekile	Ukwesekwa kwamandla eselula, i-cerebral metabolism

 

 

I-NAD+ ivamise ukuhlanganiswa nezithako ezihambisanayo zokuphila isikhathi eside ukuze kwakhe{1}}ukwakheka kwezindlela eziningi:

Isithako	Indima Engenzeka	Isicelo
I-Resveratrol	Ucwaningo lwendlela ye-Sirtuin kanye nomsebenzi we-antioxidant	Ukuphila isikhathi eside, impilo yeselula
I-Coenzyme Q10	I-Mitochondrial energy metabolism	Amandla, ukwesekwa kwenhliziyo nemithambo yegazi
I-PQQ	Ucwaningo lwe-Mitochondrial biogenesis	Impilo yamaselula, amandla
I-Glutathione	Ukuzivikela kwe-Antioxidant	Ukuvikelwa kweselula

Ukwakhiwa{0}}kwezingxenye eziningi eziqondise izimpawu zokuguga ezixhumene kuvele njengamaqhinga anamandla okuvikela i-geroprotective. Lezi zinhlanganisela zivumela amabhrendi ukuthi abeke imikhiqizo endaweni-yezinzuzo eziqondiwe eziningi kuyilapho esebenzisa ukwethembeka kwesayensi{3}}kwama-synergies afundwe kahle.

 

 

 

I-Liposomal NAD+itholakala ngamafomethi amaningi ukuze ihambisane-nezidingo zomkhiqizo oqediwe kanye nekhono lokukhiqiza:

Ifomethi	Izici	Kuhle kakhulu
Friza-impushana ye-liposomal eyomisiwe	Izinzile, kulula ukuyifaka, impilo yeshalofu enwetshiwe	Amaphilisi, amaphilisi, amaphakethe wenduku
Fafaza-impushana ye-liposomal eyomisiwe	Izakhiwo ezinhle zokugeleza, usayizi wezinhlayiyana ongaguquki	Ama-blends, ama-sachets, ukudla okusebenzayo
Ukumiswa kwe-liposomal ye-Liquid	Ulungele-ukusebenzisa{1}}ifomethi	Iziphuzo, izithako eziwuketshezi, amashothi

Abahlinzeki banikeza ukugxilisa okuhlukahlukene (imvamisa okungu-50% noma 70% okuqukethwe kwe-NAD+) ukuze kuhlangatshezwane nezidingo ezithile zokwakheka. Kubathengi be-B2B, ukutholakala kwamafomethi amaningi kunika amandla ukuthuthukiswa komkhiqizo ovumelana nezimo kuzo zonke izigaba.

 

 

Ngochwepheshe bokuthenga, ukukhetha okulungilei-liposomal NAD+ umphakeli we-powderidinga ukuhlola amapharamitha angukhiye ambalwa:

Ipharamitha	Okufanele Uqinisekise
Okuqukethwe kwe-NAD+	50%, 70%, noma imininingwane yangokwezifiso nge-HPLC eqinisekisiwe
Umthombo we-Phospholipid	Okungeyona-i-GMO sunflower noma i-soy lecithin
Ukusebenza kahle kwe-encapsulation	Umhlinzeki{0}}uchaze ukusebenza kahle okuqinisekisiwe okusekelwe ukuhlola kokuhlaziya
Usayizi wezinhlayiya	Ngaphakathi kwebanga le-nanoscale elinenkomba ye-polydispersity ephansi
Inqubo yokukhiqiza	I-high{{0}pressure homogenization noma i-microfluidization
Idatha yokuzinza	Impilo yeshelufu ebhalwe phansi ngaphansi kwezimo zokulondoloza ezinconyiwe
Ukulandeleka kwempahla eluhlaza	Uchungechunge lokunikezela olubhalwe phansi kusukela ekuhlanganiseni kuya kusithako esiqediwe
Qoqa-ukuze{1}}ukuvumelana kwenqwaba	Idatha yomlando ye-COA ebonisa ikhwalithi ekwazi ukukhiqizwa kabusha
Izitifiketi zekhwalithi	cGMP, ISO 22000, FSSC 22000, HACCP
Amadokhumenti	Iqoqo-i-COA ethile, i-TDS, i-MSDS, imibiko yokuzinza, izinsimbi ezisindayo nokuhlolwa kwe-microbial

 

 

Q: Uyini umehluko phakathi kwe-liposomal NAD+ kanye ne-NAD+ precursors njenge-NMN noma i-NR?
Izandulela ze-NAD+ (i-NMN ne-NR) zidinga ukuguqulwa kwe-enzymatic ku-NAD+ ngaphakathi komzimba. I-Liposomal NAD+ iletha i-NAD+ ngendlela ehlanganisiwe edizayinelwe ukuthuthukisa ukuzinza nokusekela ukulethwa komlomo, ngaphandle kokuthembela esilinganisweni-sokukhawulela ukuguqulwa kwama-enzyme.

Q: Yibuphi ubufakazi bomtholampilo obusekela ukwakheka kwe-liposomal NAD+?
Ucwaningo -olungahleliwe lwe-crossover olwanyatheliswa ngo-2026 lwathola ukuthi u-1,000 mg we-liposomal NAD+ nsuku zonke unyuse amazinga e-NAD+ e-intracellular ngaphezulu kwama-64% ngemva kwezinsuku eziyi-14 (p<0.01). This study provides preliminary human evidence suggesting that oral liposomal NAD+ supplementation may increase intracellular NAD+ levels. Additional clinical studies are ongoing to further evaluate the pharmacokinetics and biological effects of liposomal NAD+. Although encouraging, larger randomized controlled trials are needed to confirm these findings.

Q: Yiziphi izici okufanele abathengi bazicele ngobuningi be-liposomal NAD + powder?
Abathengi kufanele bacele okuqukethwe kwe-NAD+ (ngokuvamile okungu-50% noma u-70%), umthombo we-phospholipid, idatha ye-encapsulation, ukusatshalaliswa kosayizi wezinhlayiyana nge-DLS, i-polydispersity index, iqoqo{3}}i-COA ethile, idatha{4}}yokuzinza kwesikhathi sangempela, nezitifiketi zekhwalithi.

Q: Uyini umehluko phakathi kwe-liposomal NAD + powder kanye ne-liposomal NAD + ye-liquid?
I-Liposomal NAD+ powder ngokuvamile ikhethwa kuma-capsules, amaphilisi, nezingxube ezomile ngenxa yokuphathwa okuthuthukisiwe, ukuzinza kwezokuthutha, kanye nokuvumelana nezimo. I-Liquid liposomal NAD+ ivamise ukusetshenziselwa imikhiqizo elungele-ukuphuza{4}} kanye namashothi we-liquid supplement.

Q: Kufanele igcinwe kanjani i-liposomal NAD + powder?
Friza-izimpushana ze-liposomal ezomisiwe ngokuvamile zigcina uzinzo izinyanga ezingu-24 uma zigcinwe zivaliwe endaweni epholile, eyomile ekude nokukhanya okuqondile, ukushisa, kanye nomswakama. Ukumiswa koketshezi kungase kudinge isiqandisi.

Q: Yiziphi izitifiketi zekhwalithi okufanele umphakeli we-liposomal NAD+ azibambe?
Okungenani, bheka i-cGMP, i-ISO 22000 noma i-FSSC 22000, nesitifiketi se-HACCP. Kuya ngemakethe oyihlosile, izitifiketi ze-Kosher ne-Halal nazo zingadingeka.

 

 

I-Liposomal NAD+ imele inkundla yokwakheka ethembisayo yabakhiqizi be-B2B eqondise ukukhula okukhulayo kwesikhathi eside, amandla, kanye nezimakethe zempilo yengqondo. Ngokufaka i-phospholipid encapsulation, ubuchwepheshe bubhekana nemikhawulo ye-bioavailability eye yacindezela ngokomlando ukwakheka okujwayelekile kwe-NAD+, nobufakazi bokuqala babantu obuphakamisa ukwenyuka okunengqondo kumazinga e-NAD+ e-intracellular.

Kubathengi be-B2B-abadidiyeli, abaqondisi be-R&D, abaphathi bokuthengwa kwempahla, nabanikazi bomkhiqizo{2}}lokhu kuhumushela ezinzuzweni ezibambekayo zezentengiselwano: amaphothifoliyo omkhiqizo ahlukene, isayensi{3}}ukuthuthukiswa kokwakhiwa okunolwazi kuzo zonke izigaba eziningi, ukuma kwemakethe ye-premium, nobudlelwane obuthembekile bochungechunge lokuhlinzeka. Emakethe okucatshangwa ukuthi izofinyelela esikalini esibalulekile ngo-2033, i-liposomal NAD+ inika amandla amabhrendi ukuthi alethe okulindelekile kubathengi ukuze kube nobufakazi{7}obusekelwe, nezithako ezinempilo ezitholakalayo zokuguga ngenkathi yakhela inzuzo yokuncintisana.

 

Ingabe usukulungele ukuthuthukisa ukwakheka kwakho kwe-premium liposomal NAD+?Ithimba lethu lobuchwepheshe liyatholakala ukuze lisekele ukuthuthukiswa komkhiqizo wakho kusukela kumqondo kuya ekuqalisweni kwezentengiso. Ochwepheshe bethu bokwenza izinto bangasiza ekukhetheni isithako, ukuthuthukiswa kokwakheka, ukuhlolwa kokuhlola, amaphrojekthi we-OEM/ODM, kanye nemibhalo yokulawula yezimakethe zamazwe ngamazwe.

• Cela isampulaokokuhlola{0}kwasendlini kanye nezivivinyo zokwakha
• Cela iphakethe lamadokhumenti obuchwepheshe(COA, izifundo zokuzinza, ukuhlaziywa kosayizi wezinhlayiyana)
• Buza mayelana nokucaciswa ngokwezifiso(ukugxila, usayizi wezinhlayiya, izinketho ze-excipient)
• Hlela ukubonisana kwezobuchwepheshenososayensi bethu bokwakha

Xhumana nethimba lethu le-B2B namuhla ukuze uxoxe ngezidingo zakho zokuthola usizo. I-imeyili:liu@wellgreenxa.com

 

 

1. U-Blair E, u-Miller A, uMcDonald R. Ukhushulwe Amazinga e-Intracellular NAD+ Nge-Oral Supplementation With a Novel Liposomal Delivery Method: A Non{2}}Non{2}}I-Randomized Crossover Study.I-NDNR. 2026.
2. I-Sirtuins kanye Nezimpawu Eziyishumi Nambili Zokuguga: Uhlaka Lokuqonda Izinqubo Zokuguga kanye Nokungenelela Okuhlosiwe.Ijenali Yamazwe Ngamazwe Yesayensi Emisha Nobuchwepheshe Bokucwaninga. 2024.
3. U-Karcioglu Batur L, et al. U-Elixea ulungisa ukuphila isikhathi eside{1}}izindlela ezihlotshaniswayo kumamodeli weseli epithelial yabantu.Ukuguga Kwangaphambili. 2026. doi:10.3389/fragi.2026.1843098
4. Isigaba-Umshayeli Wendiza Olawulwa Ngokungahleliwe Ongahleliwe kanye Nocwaningo Lokwenzeka Kwe-Nicotinamide Riboside Isengezo Kubantu Abadala Abanokuphazamiseka Kwengqondo Okumaphakathi kwe-Amnestic{1}}
5. Imithelela ye-NAD+ supplementation nge-oral nicotinamide riboside kumpilo yemithambo kanye nokusebenza kwengqondo kubantu abadala asebekhulile abanesifo se-peripheral artery: Imiphumela evela esivivinyweni somtholampilo se-pilot samaviki angu-4{2}}esivulekile esinelebula.I-PubMed. 2025.
6. Isikhungo Esilindelekile, Esingasodwa{{0},Ababili-Ingalo, Ukungenelela, Okungahleliwe, Okukabili-Izimpumputhe, Eziphambanayo{3}}Ucwaningo Olungaphezu Kokuhlola Nokuqhathanisa I-Pharmacokinetics ye-NAD+ kanye Nokwakhiwa kwayo kwe-Liposomal (LNAD+) Kubantu Abadala Abanempilo. Irejista Yezilingo Zemitholampilo - I-India (CTRI/2025/07/092027). 2025.